Cytokinetics Inc (CYTK) — Cash Flow Reinvestment Rate
Cytokinetics Inc (CYTK) has a Cash Flow Reinvestment Rate of 3.33x as of December 2020, reinvesting $173.62 Million (capex $6.55 Million plus investments $-167.06 Million) from operating cash flow of $52.15 Million. Check Cytokinetics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cytokinetics Inc Cash Flow Reinvestment Rate (2009–2020)
Historical reinvestment intensity for Cytokinetics Inc across 4 annual periods. Explore Cytokinetics Inc (CYTK) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Cytokinetics Inc (2009–2020)
Year-by-year capital reinvestment analysis for Cytokinetics Inc. For live market cap and broader valuation context, see Cytokinetics Inc (CYTK) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 21.97x | $196.51 Million | $8.94 Million | $11.05 Million | ▲ +1459.5% |
| 2016 | 1.41x | $52.11 Million | $36.98 Million | $1.60 Million | ▼ -60.0% |
| 2015 | 3.52x | $17.19 Million | $4.88 Million | $562.00K | ▲ +5285.6% |
| 2009 | 0.07x | $550.00K | $8.42 Million | $550.00K | — |